SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms.
about
Serotonin levels in aqueous humor of patients with primary open-angle glaucoma.Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.Non-steroidal drug-induced glaucoma.Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients.Drug-induced Angle-Closure Glaucoma.Pharmacological and environmental factors in primary angle-closure glaucoma.Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.Bilateral acute closed angle glaucoma associated with the discontinuation of escitalopram: a case reportTopiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report.Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.Bupropion has no effect on intraocular pressure or other ophthalmologic parameters after single or repeat doses in healthy volunteers.Effects of Selective Serotonin Reuptake Inhibitors on Macular Ganglion Cell Complex Thickness and Peripapillary Retinal Nerve Fiber Layer Thickness.Effects of selective serotonin reuptake inhibitors on intraocular pressure and anterior segment parameters in open angle eyes.Antidepressants use and risk of cataract development: a systematic review and meta-analysis.Impact of aromatase absence on murine intraocular pressure and retinal ganglion cells.A case of retrobulbar optic neuritis caused by duloxetine.Evidence of ocular side effects of SSRIs and new warnings.Acute Angle-Closure Glaucoma Caused by Venlafaxine.
P2860
Q34601286-8166B5AD-2CBD-4EEF-8BD0-613E9483CFF6Q35169556-B6254089-B473-4E41-9BC5-6D06FF6A9CB4Q35226937-6E547209-EF83-4919-9D71-0D3204AD2D79Q37016842-E07C083F-3471-4B6A-9A98-FD20B8B6547FQ37507380-D125919A-840E-4B4D-B73E-4B3C091183DFQ37637415-4604B268-2D1D-42CE-B476-DD3E6E16E3DCQ37679735-E0B8CE8A-28E9-4C76-AD4B-2EBB07658AF7Q37963356-BF45C811-0309-4526-AF43-704EB0289C23Q41067164-9131A1E2-1EA3-492D-B1FE-CE791E1527FEQ41771301-B3B069A1-010A-4DBD-8E65-DB9C389BE7E6Q45300393-C80B584B-0341-4266-ABDD-8CE2CEA880DEQ46076153-6FFDD91D-7776-40ED-AF0E-6A5CD14CECAAQ47761031-FCD16780-F559-4309-A933-FFD053B37B2EQ47886119-9C856C46-5A91-43E3-B5CA-35745A11A87FQ48096424-0286A124-341D-474C-BE33-88B94D478888Q49830306-E518162C-9E13-405D-80DF-015E5A47969EQ50804089-F22BBDE1-0D03-4F48-B752-FABF64646FB7Q53622787-9DBD31D0-35A3-4E2C-A4AF-550EFA829281Q55446668-73A639FE-0556-4023-BB6E-21555932310D
P2860
SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@ast
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@en
type
label
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@ast
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@en
prefLabel
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@ast
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@en
P2093
P1433
P1476
SSRIs and intraocular pressure ...... tions and possible mechanisms.
@en
P2093
Adolfo Sebastiani
Ciro Costagliola
Francesco Parmeggiani
P304
P356
10.2165/00023210-200418080-00001
P577
2004-01-01T00:00:00Z
P6179
1042435075